Owner at BioMedReports
Contributor's Links: BioMedReports

M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began ... more

ALL CONTRIBUTIONS

NanoAntibiotics CEO Says His Firm Is Poised For Growth In Biotech's Potent Liver Disease Treatment Space
Emerging small cap firm is pioneering CIPT Technology as a potential breakthrough for the treatment of ascites, a life-threatening complication of advanced liver cirrhosis.
Read
E “New Frontier Stocks” At Play In The Battle Against Ebola
Several public companies have thrown their hats into the Ebola pandemic conversation, but only some will perform well for investors day in and day out.
Read
E Akebia Therapeutics: A Trade Opportunity With A Catalyst Ahead?
With shares trading within a technical range and an upcoming catalyst ahead, it may be time to look for a trade opportunity via Akebia Therapeutics.
Read
Imprimis' Platform Set To Bring Library Drug Formulations Quickly To Market
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) has seen its stock rise from about $5.25 per share in February at the time of the NASDAQ listing to around $9 per share and is one of the best performing stocks in the biotech industry this year.
Read

STOCKS I FOLLOW

ACCP ACCESS PHARMACEUTICL
ALKS Alkermes plc
ALTH Allos Therapeutics, Inc.
ALXA Alexza Pharmaceuticals Inc.
AMPE Ampio Pharmaceuticals, Inc.
AMRN Amarin Corporation PLC
MSTX Mast Therapeutics, Inc.
NPSP NPS Pharmaceuticals Inc.
OCLS Oculus Innovative Sciences Inc.

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications